Filter

Refine by collections

  • Metabolic Syndrome and Diabetes (18)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 18 items for :

  • Metabolic Syndrome and Diabetes x
Clear All
Niels B Dalsgaard Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Niels B Dalsgaard in
Google Scholar
PubMed Close
,
Lærke S Gasbjerg Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Lærke S Gasbjerg in
Google Scholar
PubMed Close
,
Laura S Hansen Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Laura S Hansen in
Google Scholar
PubMed Close
,
Dennis S Nielsen Department of Food Science, Faculty of Science, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Dennis S Nielsen in
Google Scholar
PubMed Close
,
Torben S Rasmussen Department of Food Science, Faculty of Science, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Torben S Rasmussen in
Google Scholar
PubMed Close
, and
Filip K Knop Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Gentofte, Denmark

Search for other papers by Filip K Knop in
Google Scholar
PubMed Close

impact of acarbose on host GM and health ( 8 , 13 , 14 , 15 ). Here, using faecal samples collected in a previously published randomised double-blind, placebo-controlled clinical trial ( 7 , 16 ), we investigated the effects of a 2-week treatment

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-24-0052
Volume/Issue:
Volume 13: Issue 7
Open access
Pernille H Hellmann Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Pernille H Hellmann in
Google Scholar
PubMed Close
,
Jonatan I Bagger Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed Close
,
Katrine R Carlander Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Katrine R Carlander in
Google Scholar
PubMed Close
,
Katrine B Hansen Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Katrine B Hansen in
Google Scholar
PubMed Close
,
Julie L Forman Section of Biostatistics, Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Julie L Forman in
Google Scholar
PubMed Close
,
Joachim Størling Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Joachim Størling in
Google Scholar
PubMed Close
,
Elizaveta Chabanova Department of Radiology, Herlev Hospital, University of Copenhagen, Herlev, Denmark

Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed Close
,
Jens Holst Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jens Holst in
Google Scholar
PubMed Close
,
Tina Vilsbøll Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed Close
, and
Filip K Knop Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Filip K Knop in
Google Scholar
PubMed Close

The study was a single-centre, randomised, double-blind, placebo-controlled, double-dummy, three-arm, parallel-group study conducted from December 2019 to June 2021 at Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0334
Volume/Issue:
Volume 12: Issue 4
Open access
Panisa Hantrakun Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Search for other papers by Panisa Hantrakun in
Google Scholar
PubMed Close
,
Rattanaporn Sekararithi Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Search for other papers by Rattanaporn Sekararithi in
Google Scholar
PubMed Close
,
Thidarat Jaiwongkam Cardiac Electrophysiology Research and Training Center (CERT), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Search for other papers by Thidarat Jaiwongkam in
Google Scholar
PubMed Close
,
Sirinart Kumfu Cardiac Electrophysiology Research and Training Center (CERT), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Search for other papers by Sirinart Kumfu in
Google Scholar
PubMed Close
,
Chatree Chai-adisaksopha Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Search for other papers by Chatree Chai-adisaksopha in
Google Scholar
PubMed Close
,
Nipon Chattipakorn Cardiac Electrophysiology Research and Training Center (CERT), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Search for other papers by Nipon Chattipakorn in
Google Scholar
PubMed Close
,
Theera Tongsong Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Search for other papers by Theera Tongsong in
Google Scholar
PubMed Close
, and
Phudit Jatavan Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Search for other papers by Phudit Jatavan in
Google Scholar
PubMed Close

-selectin and oxidative stress biomarker (8IsoP levels) between the intervention group (taking metformin) and placebo group (taking placebo) at 27–31 weeks’ gestation and before delivery (after taking drugs 6 weeks), as primary objectives and to compare the MPV

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0110
Volume/Issue:
Volume 11: Issue 4
Open access
Katrine M Lauritsen Steno Diabetes Center Aarhus, Aarhus, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Danish Diabetes Academy, Odense University Hospital, Odense, Denmark

Search for other papers by Katrine M Lauritsen in
Google Scholar
PubMed Close
,
Jens Hohwü Voigt Steno Diabetes Center Aarhus, Aarhus, Denmark

Search for other papers by Jens Hohwü Voigt in
Google Scholar
PubMed Close
,
Steen Bønløkke Pedersen Steno Diabetes Center Aarhus, Aarhus, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Steen Bønløkke Pedersen in
Google Scholar
PubMed Close
,
Troels K Hansen Steno Diabetes Center Aarhus, Aarhus, Denmark

Search for other papers by Troels K Hansen in
Google Scholar
PubMed Close
,
Niels Møller Steno Diabetes Center Aarhus, Aarhus, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Niels Møller in
Google Scholar
PubMed Close
,
Niels Jessen Steno Diabetes Center Aarhus, Aarhus, Denmark
Department of Biomedicine, Aarhus University, Aarhus, Denmark

Search for other papers by Niels Jessen in
Google Scholar
PubMed Close
,
Lars C Gormsen Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Lars C Gormsen in
Google Scholar
PubMed Close
, and
Esben Søndergaard Steno Diabetes Center Aarhus, Aarhus, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Danish Diabetes Academy, Odense University Hospital, Odense, Denmark

Search for other papers by Esben Søndergaard in
Google Scholar
PubMed Close

fatty acids in adipose tissue, we investigated the effects of 4 weeks of SGLT2 inhibition in a randomized, double-blinded, placebo-controlled crossover trial. The short duration of the intervention allowed us to determine the weight loss

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-21-0558
Volume/Issue:
Volume 11: Issue 4
Open access
Aliyu Tijani Jibril Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran

Search for other papers by Aliyu Tijani Jibril in
Google Scholar
PubMed Close
,
Ahmad Jayedi Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran

Search for other papers by Ahmad Jayedi in
Google Scholar
PubMed Close
, and
Sakineh Shab-Bidar Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran

Search for other papers by Sakineh Shab-Bidar in
Google Scholar
PubMed Close

Criteria used for inclusion of randomized controlled trials. Participants Type 2 diabetes patients (men and women), 18 years and above, with any sample size Intervention Oral supplementation of ALA ≥4 weeks Comparator Placebo

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0322
Volume/Issue:
Volume 11: Issue 10
Open access
Merlin C Thomas Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia

Search for other papers by Merlin C Thomas in
Google Scholar
PubMed Close
,
Brendon L Neuen The George Institute for Global Health, Sydney, NSW, Australia

Search for other papers by Brendon L Neuen in
Google Scholar
PubMed Close
,
Stephen M Twigg The University of Sydney School of Medicine, Sydney, NSW, Australia
Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia

Search for other papers by Stephen M Twigg in
Google Scholar
PubMed Close
,
Mark E Cooper Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia

Search for other papers by Mark E Cooper in
Google Scholar
PubMed Close
, and
Sunil V Badve The George Institute for Global Health, Sydney, NSW, Australia
Department of Renal Medicine, St George Hospital, Sydney, NSW, Australia
Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Sunil V Badve in
Google Scholar
PubMed Close

a reduced incidence of CV death (HR 0.84; 95% CI 0.74–0.96) ( 36 , 38 ), the single major cause of death in this setting. As a result, the risk of all-cause mortality was also reduced by 14% with SGLT2 inhibition treatment compared with placebo (HR

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0005
Volume/Issue:
Volume 12: Issue 8
Open access
Jonathan Hazlehurst Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Jonathan Hazlehurst in
Google Scholar
PubMed Close
,
Bernard Khoo Endocrinology, Division of Medicine, University College London, London, UK

Search for other papers by Bernard Khoo in
Google Scholar
PubMed Close
,
Carolina Brito Lobato Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Medicine, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark

Search for other papers by Carolina Brito Lobato in
Google Scholar
PubMed Close
,
Ibiyemi Ilesanmi Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK

Search for other papers by Ibiyemi Ilesanmi in
Google Scholar
PubMed Close
,
Sally Abbott Department of Dietetics, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK

Search for other papers by Sally Abbott in
Google Scholar
PubMed Close
,
Tin Chan Faculty of Medicine, Chinese University of Hong Kong, Hong Kong

Search for other papers by Tin Chan in
Google Scholar
PubMed Close
,
Sanesh Pillai Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK

Search for other papers by Sanesh Pillai in
Google Scholar
PubMed Close
,
Kate Maslin School of Nursing and Midwifery, University of Plymouth, Plymouth, UK

Search for other papers by Kate Maslin in
Google Scholar
PubMed Close
,
Sanjay Purkayastha Brunel University, London, UK
Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK

Search for other papers by Sanjay Purkayastha in
Google Scholar
PubMed Close
,
Barbara McGowan Endocrinology, Guys’ and St Thomas’s NHS Foundation Trust, London, UK

Search for other papers by Barbara McGowan in
Google Scholar
PubMed Close
,
Rob Andrews University of Exeter Medical School, Exeter, UK

Search for other papers by Rob Andrews in
Google Scholar
PubMed Close
,
Eveleigh Nicholson Portsmouth Hospitals University NHS Trust, Portsmouth, UK

Search for other papers by Eveleigh Nicholson in
Google Scholar
PubMed Close
,
Katherine McCullough Royal Surrey County Hospital, Guildford, UK

Search for other papers by Katherine McCullough in
Google Scholar
PubMed Close
,
Lorraine Albon University Hospitals Sussex NHS Foundation Trust, Worthing, UK

Search for other papers by Lorraine Albon in
Google Scholar
PubMed Close
,
Rachel Batterham Endocrinology, Division of Medicine, University College London, London, UK

Search for other papers by Rachel Batterham in
Google Scholar
PubMed Close
,
Georgios K Dimitriadis King's College Hospital NHS Foundation Trust, London, UK

Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed Close
,
Shareen Forbes BHF Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by Shareen Forbes in
Google Scholar
PubMed Close
,
Gavin Bewick School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK

Search for other papers by Gavin Bewick in
Google Scholar
PubMed Close
, and
Tricia M-M Tan Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK

Search for other papers by Tricia M-M Tan in
Google Scholar
PubMed Close

recommended international non-proprietary name avexitide) leads to the correction of hypoglycaemia and reduced hyperinsulinaemia in response to an MMT or OGTT and reduced hypoglycaemic symptoms in people with PBH ( 10 , 107 , 108 , 109 ). A phase II placebo

Article Type:
Other
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0285
Volume/Issue:
Volume 13: Issue 5
Open access
Svjatoslavs Kistkins Pauls Stradiņš Clinical University Hospital, Riga, Latvia

Search for other papers by Svjatoslavs Kistkins in
Google Scholar
PubMed Close
,
Othmar Moser Division of Exercise Physiology and Metabolism, Institute of Sport Science, University of Bayreuth, Bayreuth, Germany

Search for other papers by Othmar Moser in
Google Scholar
PubMed Close
,
Vitālijs Ankudovičs Pauls Stradiņš Clinical University Hospital, Riga, Latvia

Search for other papers by Vitālijs Ankudovičs in
Google Scholar
PubMed Close
,
Dmitrijs Blizņuks Institute of Smart Computing Technologies, Riga Technical University, Riga, Latvia

Search for other papers by Dmitrijs Blizņuks in
Google Scholar
PubMed Close
,
Timurs Mihailovs Institute of Smart Computing Technologies, Riga Technical University, Riga, Latvia

Search for other papers by Timurs Mihailovs in
Google Scholar
PubMed Close
,
Sergejs Lobanovs Pauls Stradiņš Clinical University Hospital, Riga, Latvia

Search for other papers by Sergejs Lobanovs in
Google Scholar
PubMed Close
,
Harald Sourij Trials Unit for Interdisciplinary Metabolic Medicine, Division of Endocrinology and Diabetolgoy, Medical University of Graz, Graz, Austria

Search for other papers by Harald Sourij in
Google Scholar
PubMed Close
,
Andreas F H Pfeiffer Department of Endocrinology and Metabolic Medicine, Campus Benjamin Franklin, Charité University Medicine, Hindenburgdamm, Berlin, Germany

Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed Close
, and
Valdis Pīrāgs Pauls Stradiņš Clinical University Hospital, Riga, Latvia
Faculty of Medicine, University of Latvia, Riga, Latvia

Search for other papers by Valdis Pīrāgs in
Google Scholar
PubMed Close

analogue and glucagon. Despite the effect of long-term hormonal intervention, the mean difference between the placebo and the short-term dual infusion of glucagon and GLP-1 was 146 kcal/day ( 44 ). The main implication was that GLP-1-stimulated insulin

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0529
Volume/Issue:
Volume 13: Issue 5
Open access
Marie Oertel Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Marie Oertel in
Google Scholar
PubMed Close
,
Christian G Ziegler Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany
Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany

Search for other papers by Christian G Ziegler in
Google Scholar
PubMed Close
,
Michael Kohlhaas Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Michael Kohlhaas in
Google Scholar
PubMed Close
,
Alexander Nickel Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Alexander Nickel in
Google Scholar
PubMed Close
,
Simon Kloock Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Simon Kloock in
Google Scholar
PubMed Close
,
Christoph Maack Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Christoph Maack in
Google Scholar
PubMed Close
,
Vasco Sequeira Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Vasco Sequeira in
Google Scholar
PubMed Close
,
Martin Fassnacht Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Martin Fassnacht in
Google Scholar
PubMed Close
, and
Ulrich Dischinger Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany
Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Ulrich Dischinger in
Google Scholar
PubMed Close

% compared to placebo ( 21 ). PYY, structurally related to neuropeptide Y, is co-secreted with proglucagon-derived peptides like GLP1 from L cells in the lower gut. Serum levels of PYY increase after food intake ( 22 ). Following secretion, PYY is rapidly

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0398
Volume/Issue:
Volume 13: Issue 3
Open access
Shanhong Li Department of Medical Informatics, Medical School of Nantong University, Nantong, Jiangsu Province, China

Search for other papers by Shanhong Li in
Google Scholar
PubMed Close
,
Jincheng Tao Department of Medical Informatics, Medical School of Nantong University, Nantong, Jiangsu Province, China
Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China

Search for other papers by Jincheng Tao in
Google Scholar
PubMed Close
,
Jie Tang Department of Medical Informatics, Medical School of Nantong University, Nantong, Jiangsu Province, China

Search for other papers by Jie Tang in
Google Scholar
PubMed Close
,
Yanting Chu Department of Medical Informatics, Medical School of Nantong University, Nantong, Jiangsu Province, China

Search for other papers by Yanting Chu in
Google Scholar
PubMed Close
, and
Huiqun Wu Department of Medical Informatics, Medical School of Nantong University, Nantong, Jiangsu Province, China

Search for other papers by Huiqun Wu in
Google Scholar
PubMed Close

use of placebo and the implementation of a blind method by operators, which is difficult to practically perform in the process of program-based digital technology verification. Even if RCTs have been published, these problems are worth scrutinizing

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-24-0219
Volume/Issue:
Volume 13: Issue 9
Open access